期刊文献+

S-100蛋白、PCNA在胃癌中的表达及意义 被引量:3

Expression and clinical significance of S-100 protein and PCNA antigen in gastric carcinoma
暂未订购
导出
摘要 目的探讨胃粘膜中S-100阳性细胞(S-100+DC)浸润、增殖细胞核抗原(PCNA)的表达在胃癌发生、发展中的作用及临床意义。方法应用免疫组织化学方法对57例胃癌、18例正常胃粘膜组织中的S-100+DC、PCNA进行检测。结果S-100+DC、PCNA在胃癌组中的表达均显著高于正常胃粘膜组(P<0.05)。在低分化、淋巴结转移阳性和有远处转移胃癌组织中S-100+DC数目明显减少(P<0.01)。PCNA阳性表达率与淋巴结转移、远处转移、分化程度、肿瘤大小密切相关(P<0.05),而与肿瘤浸润深度、临床分期无关(P>0.05)。胃癌组织中S-100+DC与PCNA的表达呈负相关性。结论胃粘膜微环境中S-100+DC与PCNA的变化与胃癌临床病理参数密切相关。胃癌组织内S-100+DC增多可抑制肿瘤细胞的增殖潜力,并具有抗肿瘤转移的作用。 cells ( S - 100 Objective ^+ DC) and To study the clinical significance and effects of the expression of S - 100^ + dendritic proliferating cell nuclear antigen(PCNA) in the occurrence and development of gastric carcinoma. Methods S - 100 ^+ DC and PCNA expression was detected in 43 specimens of gastric carcinoma,24 cases of normal gastric mucosa using immunohistochemistry. Results The expression of S - 100 ^+ DC and PCNA in gastric carcinoma was markly higher than in normal gastric mucosa ( P 〈 0.05). The number of S -100^ + DC in the gastric carcinoma tissues withlow differentiation, lymph node and distant metastasis was significantly lower ( P 〈 0.01 ). The positive rates of PCNA were correlated with lymph node metastasis, diatant metastasis, degree of differentiation, tumor size ( P 〈 0.05 ), and no relation with depth of invasion and clinical stage ( P 〉 0.05 ). A negative relationship was found between S - 100 ^+ DC and PCNA expressions in gastric cancer. Conclusion The change of S - 100 ^+ DC and HLA - DR in gastric mucosa were closely correlated with the clinical pathological parameters of gastric carcinoma. S - 100 ^+ DC in gastric cancer might play a role in inhibiting the growth of tumor cells and anti - tumor metastasis.
出处 《中原医刊》 2006年第6期1-3,共3页 Central Plains Medical Journal
关键词 树突状细胞 增殖细胞核抗原 胃癌 免疫组织化学 Dendritic cells Proliferating cell nuclear antigen Gastric carcinoma Immunohistochemistry
  • 相关文献

参考文献8

  • 1Mayordomo JI, Zorina T, Storkus WJ, et al. Bone marrow - derived dendritic cells puled with synthetic tumour peptides elicit protective and therapeutic antitumour immunity. Nat Med, 1995,1 ( 12 ) : 1297-1302.
  • 2Tsujitani S, Kakeji Y, Watanabe A ,et al. Infiltration of dendritic cells in relation to tumor invasion and lymph node metastasis in human gastric cancer. Cancer, 1990,66:2012 - 2016.
  • 3Pirtskhalaishvili G,Shurin GV, Gambotto A, et al. Tranduction of dendritic cells whh Bcl - XL increases their resistance to prostate cancer -induced apoptosis and antitumor effect in mice. J Immunol,2000, 165(4) :1956-1964.
  • 4Yu B,Kusmartsev S,Cheng F,et al. Effective combination of chemotherapy and dendritic cell administration for the treatment of advanced stage experimental breast cancer. Clin Cancer Res ,2003,9 ( 1 ) :285 - 294.
  • 5Su Z,Dannull J,Heiser A,et al. Immunological and clinical responses in metastatic renal cancer patients vaccinated with tumor RNA - transfected dendritic cells. Cancer Res.2003,63(9) :2127 -2133.
  • 6Noda H, Laehara Y, Irie K, et al. Increased proliferative activity caused by loss of P21 ( WAF1/CIP1 ) expression and its clinical significance in patients with early - stage gastric carcinoma. Cancer , 2002 , 94 (7) :2107-2112.
  • 7Konno S, Takebayashi Y, Aiba I,et al. Clinicopathological and prognostic significance of thymidine phosphnrylase and proliferating cell nuclear antigen in gastric cancinoma, Cancer Lett.2001,166 ( 1 ) : 103-111.
  • 8Kekow J, Wiedemann GJ. Transforming growth factorβ: a cytokine with multiple actions in oncology and potential clinical applications.Int J Oncol, 1995,7 : 177-182.

同被引文献28

  • 1李晓艳,中岛格,董频.树突状细胞表型抗原在喉咽癌颈部淋巴结中的表达[J].临床耳鼻咽喉科杂志,2006,20(3):110-113. 被引量:1
  • 2郑维锷,孙利敏,林讷.p53、PCNA在胃癌中的表达[J].肿瘤学杂志,2006,12(2):160-160. 被引量:2
  • 3HE Y, ZHANG J, DONAHUE C, et al. Skin-derived dendritic cells induce potent CD8( + ) T cell immunity in recombinant lentivector-mediated genetic immunization [J]. Immunity,2006,24(5):643-656.
  • 4PEREZ L, SHURIN M R, COLLINS B, et al. Comparative analysis of CD1a, S-100, CD83, and CD11c human dendritic cells in normal,premalignant,and malignant tissues[JJ. Histol Histopathol, 2005,209 (4) : 1165-1172.
  • 5BOBRYSHEV Y V, LORD R S. 55-kD actin-bundling protein(p55) is a specific marker for identifying vascular dendritic cells[J]. J Histochem Cytochem, 1999,47(11): 1481-1486.
  • 6MAEDA K, MATSUDA M, SUZUKI H, et al. Immunohistochemical recognition of human follicular dendritic cells(FDCs)in routinely processed paraffin sections[J]. J Histochem Cytochem ,2002,50(11):1475-1485.
  • 7ENGERING A, VAN VLIET S J, HEBEDA K, et al.Dynamie populations of dendritic cell-specific ICAM-3 grabbing nonintegrin-positive immature dendritic cells and liver/lymph node-specific ICAM-3 grabbing nonintegrin-positive endothelial cells in the outer zones of the paracortex of human lymph nodes[J]. Am J Pathol,2004,164(5):1587-1595.
  • 8MC NEILLY T N, BROWN J K, HARKISS G. Differential expression of cell surface markers by ovine respiratory tract dendritic cells[J]. J Histochem Cytochem ,2006,54(9) : 1021-1030.
  • 9SATO H,DOBASHI M. Ultrastructural localization of S-100 protein in rat popliteal lymph nodes,and very slight proliferative activity of follicular dendritic cells [J]. Histol Histopathol ,1996 ,11( 3 ) :703-709.
  • 10YAMATE J, YOSHIDA H, TSUKAMOTO Y, et al. Distribution of cells immunopositive for AM 3K, a novel monoclonal antibody recognizing human macrophages, in normal and diseased tissues of dogs,cats,horses,cattle,pigs,and rabbits[J]. Vet Pathol,2000,37(2) : 168-176.

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部